Medical Xpress reports on PET imaging's growing role in Alzheimer's drug selection
Medical Xpress reports that nuclear medicine is playing an increasingly important role in the diagnosis and treatment of Alzheimer's disease . Medical Xpress reports that amyloid PET imaging is used to confirm the presence of amyloid pathology and to support treatment decisions for patients receiving anti‑amyloid drugs . Medical Xpress reports that tau PET scans can provide additional information about disease progression and prognosis . Medical Xpress reports that brain PET scans help select and monitor patients for new Alzheimer's drugs . Medical Xpress reports that at the 39th Annual Congress of the European Association of Nuclear Medicine (EANM'26) in Vienna from Oct 17‑21, experts will discuss first experiences with these PET scans in routine clinical use and explore the latest advances in nuclear medicine .
Why it matters. Medical Xpress reports that the congress discussions will provide clinicians with emerging insights into applying PET imaging for therapy selection, potentially influencing patient management .